Novel Oral Anticoagulants at 10: An Assessment of their Safety and Contemporary Use in Atrial Fibrillation

Dr John Eikelboom is an Associate Professor in the Department of Medicine at McMaster University in Hamilton , Ontario . 

Dr Eikelboom earned his MBBS degree at the University of Western Australia Medical School, Australia and he completed training in Internal Medicine and Haematology at Royal Perth Hospital , Australia and trained in Epidemiology and Thrombosis Medicine at McMaster University . 

Dr Eikelboom’s current research focuses on variable response to antiplatelet therapy, antithrombotic therapy in atrial fibrillation, and mechanisms and prognosis of bleeding. He has published more than 150 peer-reviewed papers. He is a member of the Editorial Board for Stroke and on the Advisory Board for the Journal of Thrombosis and Haemostasis.

Prof. Ken Okumura served as a Professor of Medicine at Hirosaki University School of Medicine from 1996 to 2016. He also served as a President of the Japanese Heart Rhythm Society (JHRS) from 2012 to 2016. He is now working at Saiseikai Kumamoto Hospital Cardiovascular Center, Japan, while providing the latest interventional treatments for cardiac arrhythmias especially catheter ablation of AF. His main interests include pharmacological and non-pharmacological treatments of cardiac arrhythmias, catheter ablation of persistent AF, and oral anticoagulant therapy for stroke prevention in AF especially in the elderly AF patients.

Professor Jan Steffel is a cardiologist based in Zurich, Switzerland, where he serves as Senior Consultant in Electrophysiology and Cardiac Devices at the Hirslanden Clinic and Professor of Cardiology at the University of Zurich. He is widely recognised for his expertise in cardiac rhythm disorders and device-based therapies and combines a high-volume clinical practice with academic research and education at an international level.

Academic History

Professor Steffel is board-certified in Internal Medicine and Cardiology and holds advanced professional certifications in Invasive Electrophysiology and Cardiac Devices from both the European Heart Rhythm Association (EHRA) and the International Board of Heart Rhythm Examiners (IBHRE). His academic output includes more than 150 publications in national and international peer-reviewed journals. He has also co-authored two textbooks focusing on General Cardiology and Anticoagulation, contributing to postgraduate…

Stefan H Hohnloser is Professor of Medicine and Cardiology at the Johann Wolfgang Goethe University in Frankfurt, Germany, where he is the Head of the Department of Electrophysiology. His primary research interests include sudden cardiac death and its prevention by device therapy.